ArticleJournal for immunotherapy of cancer2022

Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors.

Marina Natoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.